S&P 500   0.64 (+1.11%)
DOW   0.64 (+1.11%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
S&P 500   0.64 (+1.11%)
DOW   0.64 (+1.11%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
S&P 500   0.64 (+1.11%)
DOW   0.64 (+1.11%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
S&P 500   0.64 (+1.11%)
DOW   0.64 (+1.11%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
Log in

NASDAQ:CDNACareDx Stock Price, Forecast & News

$33.52
-0.41 (-1.21 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$33.34
Now: $33.52
$35.84
50-Day Range
$30.17
MA: $32.73
$35.69
52-Week Range
$13.04
Now: $33.52
$38.58
Volume491,200 shs
Average Volume739,322 shs
Market Capitalization$1.49 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.07
CareDx, Inc., a precision medicine company, discovers, develops, and commercializes healthcare solutions for transplant patients and caregivers worldwide. It offers AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; and AlloMap Heart, a gene expression solution for heart transplant patients. The company also develops, manufactures, markets, and sells products that increase the chance of successful transplants by facilitating a match between a donor and a recipient of stem cells and solid organs. In addition, it offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables precision in HLA typing at a low to intermediate resolution for samples that uses real-time polymerase chain reaction methodology; and TruSight HLA, a solution for use in transplantation diagnostic testing. Further, the company provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Ottr, a transplant patient tracking software; and XynQAPI and Waitlist Management solutions. It offers its products directly to customers, as well as through third-party distributors. The company has a license agreement with Illumina, Inc. for the development, commercialization, and distribution of next generation sequencing product line for use in transplantation diagnostic testing; and Cibiltech SAS to commercialize KidneyCare iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in South San Francisco, California.
Read More
CareDx logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.35 out of 5 stars


Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CDNA
CUSIPN/A
Phone415-287-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$127.07 million
Book Value$2.33 per share

Profitability

Net Income$-21,970,000.00

Miscellaneous

Employees306
Market Cap$1.49 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive CDNA News and Ratings via Email

Sign-up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter.

CareDx (NASDAQ:CDNA) Frequently Asked Questions

How has CareDx's stock been impacted by COVID-19 (Coronavirus)?

CareDx's stock was trading at $18.94 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CDNA stock has increased by 77.0% and is now trading at $33.52. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of CareDx?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CareDx.

When is CareDx's next earnings date?

CareDx is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for CareDx.

How were CareDx's earnings last quarter?

CareDx Inc (NASDAQ:CDNA) released its quarterly earnings data on Thursday, April, 30th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by $0.01. The company earned $38.40 million during the quarter, compared to the consensus estimate of $38.26 million. CareDx had a negative return on equity of 20.72% and a negative net margin of 14.53%. The firm's quarterly revenue was up 47.8% on a year-over-year basis. During the same quarter last year, the company posted $0.05 EPS. View CareDx's earnings history.

What price target have analysts set for CDNA?

6 brokerages have issued 12 month price objectives for CareDx's stock. Their forecasts range from $37.00 to $63.00. On average, they anticipate CareDx's stock price to reach $46.00 in the next year. This suggests a possible upside of 37.2% from the stock's current price. View analysts' price targets for CareDx.

Has CareDx been receiving favorable news coverage?

News headlines about CDNA stock have trended very negative this week, according to InfoTrie. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. CareDx earned a daily sentiment score of -3.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about CareDx.

Who are some of CareDx's key competitors?

What other stocks do shareholders of CareDx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Roku (ROKU), EXACT Sciences (EXAS), Square (SQ), Advanced Micro Devices (AMD), Alibaba Group (BABA), NVIDIA (NVDA), Netflix (NFLX), Activision Blizzard (ATVI), Aduro BioTech (ADRO) and Johnson & Johnson (JNJ).

Who are CareDx's key executives?

CareDx's management team includes the following people:
  • Dr. Peter Maag, Chairman & CEO (Age 53, Pay $1.08M)
  • Dr. Reginald Seeto, Pres & Chief Bus. Officer (Age 48, Pay $826k)
  • Mr. Michael Bell, Chief Financial Officer (Age 51, Pay $686.59k)
  • Ms. Sasha King M.B.A., Chief Marketing Officer (Age 34, Pay $509.2k)

What is CareDx's stock symbol?

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

Who are CareDx's major shareholders?

CareDx's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.04%). Company insiders that own CareDx stock include James P Yee, Michael Brian Bell, Michael Goldberg, Neil Gagnon, Peter Maag, Sasha King and William A Hagstrom. View institutional ownership trends for CareDx.

Which institutional investors are buying CareDx stock?

CDNA stock was bought by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc.. View insider buying and selling activity for CareDx.

How do I buy shares of CareDx?

Shares of CDNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CareDx's stock price today?

One share of CDNA stock can currently be purchased for approximately $33.52.

How big of a company is CareDx?

CareDx has a market capitalization of $1.49 billion and generates $127.07 million in revenue each year. The company earns $-21,970,000.00 in net income (profit) each year or ($0.52) on an earnings per share basis. CareDx employs 306 workers across the globe.

What is CareDx's official website?

The official website for CareDx is www.caredxinc.com.

How can I contact CareDx?

CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-287-2300 or via email at [email protected]

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.